Comunicati Stampa
Salute e Benessere

Responsibility statement for first half year of 2024

Please find attached the first half 2024 financial report including the Responsibility Statement.***** For further information, please contact: Alexander Karlsen CFO +47 97 05 36 21 Alexander.karlsen@vistin.comThis information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act Attachment Vistin Pharma ASA Q2 report 2024
Oslo, (informazione.it - comunicati stampa - salute e benessere)

Please find attached the first half 2024 financial report including the Responsibility Statement.

*****

For further information, please contact:

Alexander Karlsen
CFO
+47 97 05 36 21
Alexander.karlsen@vistin.com

This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act

Attachment


Per maggiori informazioni
Ufficio Stampa
 Nasdaq GlobeNewswire (Leggi tutti i comunicati)
2321 Rosecrans Avenue. Suite 2200
90245 El Segundo Stati Uniti
Allegati
Non disponibili